The pre-proposal period is open for Therapeutics/Cancer Therapeutics/Drug Development – Accelerating Cancer Therapeutics (ACT) & Translational Therapeutics Resource (TRx); and Medical Technologies/Devices/Software/Coordination of Care/Remote Medicine – Biomedical Engineering Technology Accelerator (BiomedX formerly Columbia-Coulter program). Applicants must have a full-time faculty appointment, and at least one of the lead investigators should be from Columbia University. Graduate students and post-doctorate trainees can act as a project lead, with permission from the principal investigators (PIs). Please refer to the individual program Pre-proposal Instructions (below) and/or reach out to L2M@ctv.columbia.edu.
- This event has passed.